Table of Contents
November 01, 2011; Volume 9, Issue 3-4-
C-B3-01: Building Toward a Patient-Centered Culture: Insights and Tactics from Literature, Health System Stakeholders, and Patients
Sarah Greene, Leah Tuzzio and Dan Cherkin- Clinical Medicine & Research November 2011, 9 (3-4) 159;
- DOI: https://doi.org/10.3121/cmr.2011.1020.c-b3-01
-
PS1-40: Laboratory Monitoring of HEDIS Medications in the Ambulatory Setting: The Relative Contribution of Physician and Patient Behavior to Undermonitoring
Jennifer Tjia, Terry Field, Marsha Raebel, Shira Fischer, Dan Peterson, Yanfang Zhao, Shawn Gagne and Jerry Gurwitz- Clinical Medicine & Research November 2011, 9 (3-4) 178-179;
- DOI: https://doi.org/10.3121/cmr.2011.1020.ps1-40
-
C-B1-01: Psychotherapeutic Prescription Patterns Across Health Plans in the Mental Health Research Network
Christine Stewart, Greg Simon, Irina Miroshnik, Brian Ahmedani, Matthew Lakoma, Dana Larkin, Karen Niedenfuer, Robin Whitebird, Carsie Nyirenda, Arne Beck, Marvin Adams, Robert Davis, Mark Schmidt, Ameena Ahmed, Jamila Gul, Phillip Crawford, Frances Lynch, Julie Liu and Karen Coleman- Clinical Medicine & Research November 2011, 9 (3-4) 183;
- DOI: https://doi.org/10.3121/cmr.2011.1020.c-b1-01
-
PS2-33: Patient Characteristics Associated with Medication Adherence
Sharon Rolnick, Richard Bruzek, Pamala Pawloski, Brita Hedblom, Stephen Asche, Dana Meier and Maren Fustgaard- Clinical Medicine & Research November 2011, 9 (3-4) 158;
- DOI: https://doi.org/10.3121/cmr.2011.1020.ps2-33
-
PS2-32: Barriers and Facilitators for Medication Adherence
Sharon Rolnick, Pamala Pawloski, Richard Bruzek, Brita Hedblom, Stephen Asche, Maren Fustgaard and Dana Meier- Clinical Medicine & Research November 2011, 9 (3-4) 157;
- DOI: https://doi.org/10.3121/cmr.2011.1020.ps2-32
-
PS1-09: Readmission and 30-day Mortality Among CAP Patients in Two Systems of Care
Laurel Copeland, Debbie Godwin, Dean Kjar, Daniel MacCarthy and Dennis Myers- Clinical Medicine & Research November 2011, 9 (3-4) 170;
- DOI: https://doi.org/10.3121/cmr.2011.1020.ps1-09
-
C-A1-01: Using Data Transformations, Derived Values, and Cryptographic Functions to Protect PHI in the VDW
Daniel Ng- Clinical Medicine & Research November 2011, 9 (3-4) 183;
- DOI: https://doi.org/10.3121/cmr.2011.1020.c-a1-01
-
PS2-16: Patient Knowledge and Beliefs Concerning Gout and Its Treatment
Leslie Harrold, Kathleen Mazor, Daniel Peterson, Cassandra Firneno and Robert Yood- Clinical Medicine & Research November 2011, 9 (3-4) 155;
- DOI: https://doi.org/10.3121/cmr.2011.1020.ps2-16
-
PS2-10: Anticoagulant Treatment of Venous Thromboembolism in Cancer Patients: Preliminary Findings
Thomas Delate, Daniel Witt, Debra Ritzwoller, Stephanie Latimer, Addie Clark, Deborah Schrag, Jane Weeks, Lawrence Kushi and Mark Hornbrook- Clinical Medicine & Research November 2011, 9 (3-4) 145;
- DOI: https://doi.org/10.3121/cmr.2011.1020.ps2-10
-
C-B5-01: Childhood Obesity: Risk Factors, Associated Morbidity and Service Utilization
Revital Gross, Daphna Doron, Yael Ashkenazi, Beatriz Hemo, Orit Ben Shoham and Israela Nahshon- Clinical Medicine & Research November 2011, 9 (3-4) 154;
- DOI: https://doi.org/10.3121/cmr.2011.1020.c-b5-01
Dan Cherkin
Dan Peterson
Dana Larkin
Dana Meier
Daniel MacCarthy
Daniel Ng
Daniel Peterson
Daniel Witt
Daphna Doron
In this Issue
Issue Highlights
- Blood Type, Hormone Receptor Status, HER2/neu Status, and Survival in Breast Cancer: A Retrospective Study Exploring Relationships in a Phenotypically Well-Defined Cohort
- Absence of Novel CYP4F2 and VKORC1 Coding Region DNA Variants in Patients Requiring High Warfarin Doses
- Collaborations in Population-Based Health Research
- Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival
- Birds, Migration and Emerging Zoonoses: West Nile Virus, Lyme Disease, Influenza A and Enteropathogens
- Patient Characteristics Associated with Medication Adherence
- Healthcare Workers Emotions, Perceived Stressors and Coping Strategies During a MERS-CoV Outbreak
- Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer


